Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal(Heidelberg University), Timm Denecke(Leipzig University), Ingo Einspieler(University Hospital Regensburg), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Henning Wege(Universität Hamburg), Nikolaos Kartalis(Karolinska University Hospital), Max Seidensticker(LMU Klinikum), David Pasquier(Centre National de la Recherche Scientifique), Bernhard Gebauer, Daniela Elena Oprea-Lager, Roberto Cannella, Christoph Johannes Zech, Wolfgang Gerhard Kunz, Arndt Vogel, Bruno Sangro, Irene Bargellini(Candiolo Cancer Institute), Roberto Iezzi, Felix M. Mottaghy(College Board)
RWTH Publications (RWTH Aachen)
January 1, 2025
Cited by 0
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299